Casslén B
Contraception. 1982 Feb;25(2):191-7. doi: 10.1016/0010-7824(82)90030-0.
The normally occurring fibrinolytic activity of uterine fluid was used to evaluate the possibility of influencing fibrinolytic enzymes liberated in the uterine cavity in humans. Oral and intravenous administration of a synthetic fibrinolytic inhibitor, tranexamic acid, was found to significantly suppress the fibrinolytic activity of uterine fluid during the luteal phase. The significance of this observation is discussed in relation to the possible participation of fibrinolytic enzymes during the implantation process in humans as in some other species.
利用子宫液中正常存在的纤溶活性来评估影响人体子宫腔内释放的纤溶酶的可能性。研究发现，口服和静脉注射合成纤溶抑制剂氨甲环酸可显著抑制黄体期子宫液的纤溶活性。结合纤溶酶在人类着床过程中可能像在其他一些物种中那样发挥作用，对这一观察结果的意义进行了讨论。
